Morning Ankle Failure: When 'Foot Drop' Mimics a Stroke
If you wake up, step out of bed, and suddenly find your ankle giving out—making it nearly impossible to plant your foot firmly on the ground—you may...
Search results for "ear"
“I’m Addicted”: BLACKPINK’s Jisoo Reveals Toned Abs and the Secret Behind Her Physique
BLACKPINK’s Jisoo recently captivated fans by showcasing her defined core. On the 23rd, Jisoo shared editorial photos and behind-the-scenes glimpses...
Heartburn That Won't Quit? 6 Warning Signs That May Signal Stomach Cancer
Stomach cancer is frequently linked to dietary habits, such as the regular consumption of excessively salty or spicy...
Korea’s 40th New Drug ‘Nuviju’ Launches: A Three-Way Battle for the Double-Chin Market
Medytox is set to shake up the aesthetic medicine industry with the launch of "Nuviju," a new treatment for submental...
Why Your Perfect Brushing Routine Isn't Stopping "Spring Bad Breath"
Bad breath is a sensitive issue that transcends simple hygiene; it can deeply impact interpersonal relationships and...
Oscotec to Present Kidney Failure Treatment Candidate at World Congress of Nephrology in Japan
Oscotec announced on the 23rd that it will present animal-model proof-of-concept results for a new drug candidate...
"Eel of the Mountains": Why Model Yano Shiho Calls Chinese Yam a Stamina Essential
Japanese model Yano Shiho, known for her disciplined approach to health and as the wife of MMA star Choo Sung-hoon,...
![[USA-NIH] Why the NIH, Home to 174 Nobel Laureates, Attracts a Global Elite of Physician-Scientists](https://cdn.kormedi.com/wp-content/uploads/2025/09/gettyimages-2225315935.jpg)
[USA-NIH] Why the NIH, Home to 174 Nobel Laureates, Attracts a Global Elite of Physician-Scientists
The chronic crisis in domestic healthcare extends beyond the collapse of essential services; it is also a crisis of...
HK inno.N’s ‘Ecnoglutide’: Can a Late Entrant’s “Hidden Card” Reshape the Obesity Market?
HK inno.N is fast-tracking the South Korean launch of ecnoglutide, a GLP-1 receptor agonist licensed from China’s...
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...